Ad
BIO - Bio Rad Laboratories Class A Stock Trading
About | Bio-Rad Laboratories Inc. Class A (NYSE:BIO)
Not available
Quote | Bio-Rad Laboratories Inc. Class A (NYSE:BIO)
| Last: | $308.93 |
|---|---|
| Change Percent: | 0.64% |
| Open: | $305.03 |
| Close: | $308.93 |
| High: | $310.5537 |
| Low: | $302.655 |
| Volume: | 437,498 |
| Last Trade Date Time: | 12/04/2023 03:00:00 am |
News | Bio-Rad Laboratories Inc. Class A (NYSE:BIO)
-
2023-11-25 05:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
2023-11-15 10:41:34 ET More on JFrog, Louisiana-Pacific, etc. Spectrum Brands Holdings: A Messy But Appealing Prospect Heading Into Q4 Earnings JFrog: A High-Quality Company With Little Margin of Safety Raymond James cuts Masimo to market perform, cites lack of visib...
Message Board Posts | Bio-Rad Laboratories Inc. Class A (NYSE:BIO)
| Subject | By | Source | When |
|---|---|---|---|
| Long and strong lets hope im right | SAE | investorshub | 05/02/2023 5:06:29 PM |
| $BIO When is this gonna take off? | buhg1b | investorshub | 05/01/2023 2:34:39 AM |
| $BIO Price gaining | SAE | investorshub | 04/30/2023 5:11:47 PM |
| $BIO Price trading last up | PirateGary | investorshub | 04/30/2023 1:08:44 AM |
| $BIO MomentumIts now | locksflooring | investorshub | 04/25/2023 2:33:56 AM |
News, Short Squeeze, Breakout and More Instantly...
Bio-Rad Laboratories Inc. Class A Company Name:
BIO Stock Symbol:
NYSE Market:
Ad
-
2023-11-25 05:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
Bio-Rad Laboratories Inc (NYSE: BIO) shares are trading lower after the company lowered its annual revenue growth forecast, citing the uncerta...
-
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostics products, today announced financial results for the third quarter ended September 30, 2023. Third-quarter 2023 total net sales were $632.1 million, a decrease of 7.1 percent comp...